See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Marine Le Pen
Eid
Natural Disasters
Social Media
Artificial Intelligence
Baseball
Donald Trump
Tariffs
2024 French Elections
Amazon
MLB
NCAA
Published • loading... • Updated

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

Summary by PharmaVOICE
After Tezspire reduced the need for nasal polyp surgery by 98% in patients with a severe respiratory condition, the biopharma giants are even more ambitious for the next wave of biologic medicines.

1 Articles

All
Left
Center
1
Right
PharmaVOICEPharmaVOICE
Center

How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology

After Tezspire reduced the need for nasal polyp surgery by 98% in patients with a severe respiratory condition, the biopharma giants are even more ambitious for the next wave of biologic medicines.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PharmaVOICE broke the news in on Thursday, March 27, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Amgen

Amgen

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal